HELP Committee Approves Protection For High Tech Drug Companies From Generics
“Senators agreed Monday to give hightech biologic drugs 12 years of market protection before generic versions can compete,” according to The Associated Press.
The AP reports “The vote in the Senate Health, Education, Labor and Pensions Committee was a victory for the biotechnology and pharmaceutical industries but a defeat for the Obama administration and AARP. The [...]